

Latest Posts
Il est temps de sonner l‘alarme
In MedicalHealth Canada approves Fasenra® (benralizumab injection) as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis
In News & Updates, UncategorizedAsthma Canada Launches Bold New 5-Year Strategic Plan: A Pathway to a Symptom-Free Future
In News & UpdatesAsthma Canada Partners with Sun Life to Advance Personalized Asthma Care in Canada
In News & Updates, UncategorizedBreathing Easy This Pollen Season
In News & Updates